The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2026

Filed:

Dec. 05, 2022
Applicant:

Access Medical Systems, Ltd., Palo Alto, CA (US);

Inventors:

Robert F. Zuk, Menlo Park, CA (US);

Mohsen Karbaschi, Santa Clara, CA (US);

Heng Wu, Shanghai, CN;

Haode Chen, Shanghai, CN;

Assignee:

ACCESS MEDICAL SYSTEMS, LTD., Palo Alto, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/58 (2006.01); C07K 16/104 (2026.01); G01N 21/64 (2006.01); G01N 33/543 (2006.01); G01N 33/557 (2006.01);
U.S. Cl.
CPC ...
G01N 33/582 (2013.01); C07K 16/104 (2026.01); G01N 21/6428 (2013.01); G01N 33/543 (2013.01); G01N 33/557 (2013.01); G01N 2021/6439 (2013.01);
Abstract

The present invention is directed to a method of measuring the dissociation rate of the binding of an antibody to an antigen. The method has two phases: a first phase of binding and a second phase of dissociation. The first phase of the assay has a probe coated with an antigen, or protein G, or an anti-human IgG Fc antibody. The probe is immersed in a sample solution containing an antibody, followed by a wash sequence, then the probe is transferred to a reagent with a biotinylated antigen. After an incubation, the antibody bound on the probe binds to the biotinylated antigen to form an immune complex. Fluorescent signal is produced by immersing the probe in a reagent having a fluorescent tagged streptavidin. The last step of the first phase is a measurement of fluorescent on the probe tip. The second phase of the assay is making subsequent fluorescent measurements over time to monitor the loss in fluorescence indicating dissociation of the immune complex and calculating the dissociation rate of the binding of the antibody to the antigen.


Find Patent Forward Citations

Loading…